• Applied Therapeutics Inc APLT.OQ APLT.O is expected to show a rise in quarterly revenue when it reports results on August 5 (estimated) for the period ending June 30 2025

• The New York City-based company is expected to report a 189.4% increase in revenue to $416.67 thousand from $144 thousand a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Applied Therapeutics Inc is for a loss of 16 cents per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Applied Therapeutics Inc is $2.50, about 82% above its last closing price of $0.45

Previous quarterly performance (using preferred earnings measure in US dollars). ​

This summary was machine generated August 1 at 13:28 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)